LONDON, July 4 (Reuters) - British sexual health specialist Futura Medical Plc (FUM.L: Quote, Profile, Research) signed a long-awaited agreement with GlaxoSmithKline Plc (GSK.L: Quote, Profile, Research) on Tuesday to develop its gel MED2002 as a non-prescription treatment for impotence.
